You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.
|
|---|---|
| Published in |
Current Pharmaceutical Design, January 2012
|
| DOI | 10.2174/138161212802884780 |
| Pubmed ID | |
| Authors |
R Martin-Santos, J A Crippa, A Batalla, S Bhattacharyya, Z Atakan, S Borgwardt, P Allen, M Seal, K Langohr, M Farré, A W Zuardi, P K McGuire |
| Abstract |
Animal and humans studies suggest that the two main constituents of cannabis sativa, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have quite different acute effects. However, to date the two compounds have largely been studied separately. |
X Demographics
The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 30% |
| United Kingdom | 4 | 20% |
| Central African Republic | 1 | 5% |
| Unknown | 9 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 15 | 75% |
| Scientists | 2 | 10% |
| Practitioners (doctors, other healthcare professionals) | 2 | 10% |
| Science communicators (journalists, bloggers, editors) | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 426 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | <1% |
| United States | 2 | <1% |
| United Kingdom | 1 | <1% |
| Germany | 1 | <1% |
| Unknown | 420 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 76 | 18% |
| Student > Master | 54 | 13% |
| Student > Ph. D. Student | 53 | 12% |
| Researcher | 46 | 11% |
| Other | 27 | 6% |
| Other | 62 | 15% |
| Unknown | 108 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 70 | 16% |
| Neuroscience | 45 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 40 | 9% |
| Agricultural and Biological Sciences | 35 | 8% |
| Psychology | 33 | 8% |
| Other | 77 | 18% |
| Unknown | 126 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 52. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 May 2023.
All research outputs
#835,697
of 25,789,020 outputs
Outputs from Current Pharmaceutical Design
#39
of 3,725 outputs
Outputs of similar age
#4,614
of 251,972 outputs
Outputs of similar age from Current Pharmaceutical Design
#4
of 215 outputs
Altmetric has tracked 25,789,020 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,725 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,972 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 215 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.